Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...

The $599 price is also vastly lower than the other GLP-1s offered on Hims & Hers: it provides Ozempic for $1,799 a month, Mounjaro for $1,899 a month and Zepbound for $1,899 a month. This is a ...

Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...

Hims & Hers (HIMS) stock popped more than 20% in ... with Ro to offer vials of Eli Lilly's blockbuster weight loss drug Zepbound. Novo Nordisk's partnership focuses on the injectable pens ...